Aurinia Pharmaceuticals, Inc.

Aurinia Pharmaceuticals, Inc. price (AUPH)

$0.00
USD 0.00(0.00%)
1 month
Volume
Market Cap
52 Week
High
Low
Prev. Close

About Aurinia Pharmaceuticals, Inc.

Operates as a biopharmaceutical company, which focuses on discovery and development of immunomodulating therapeutics

Sector
Health Technology
CEO
Richard M. Glickman
Industry
Biotechnology
Exchange
NAS

Top Stories

Coming soon.